Clark Capital Management Group Inc. Increases Position in HCA Healthcare, Inc. (NYSE:HCA)

Clark Capital Management Group Inc. boosted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCAGet Rating) by 91.9% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 165,464 shares of the company’s stock after buying an additional 79,230 shares during the period. Clark Capital Management Group Inc.’s holdings in HCA Healthcare were worth $42,511,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the business. Putnam Investments LLC grew its position in shares of HCA Healthcare by 467.3% in the 3rd quarter. Putnam Investments LLC now owns 1,067,246 shares of the company’s stock valued at $259,042,000 after buying an additional 879,114 shares during the last quarter. Franklin Resources Inc. lifted its stake in shares of HCA Healthcare by 70.1% in the third quarter. Franklin Resources Inc. now owns 1,756,063 shares of the company’s stock valued at $426,232,000 after purchasing an additional 723,733 shares during the period. TD Asset Management Inc. lifted its stake in shares of HCA Healthcare by 60.9% in the fourth quarter. TD Asset Management Inc. now owns 849,594 shares of the company’s stock valued at $218,278,000 after purchasing an additional 321,524 shares during the period. Renaissance Technologies LLC acquired a new position in HCA Healthcare during the fourth quarter worth about $81,546,000. Finally, Two Sigma Investments LP grew its holdings in shares of HCA Healthcare by 415.2% during the third quarter. Two Sigma Investments LP now owns 358,761 shares of the company’s stock worth $87,078,000 after buying an additional 289,130 shares in the last quarter. Institutional investors own 67.87% of the company’s stock.

A number of equities research analysts recently issued reports on the stock. UBS Group lowered their target price on shares of HCA Healthcare from $289.00 to $241.00 and set a “buy” rating for the company in a report on Tuesday, April 26th. TheStreet raised shares of HCA Healthcare from a “c+” rating to a “b-” rating in a research report on Monday, March 21st. Truist Financial reduced their target price on shares of HCA Healthcare from $310.00 to $250.00 and set a “buy” rating on the stock in a research report on Monday, April 25th. SVB Leerink cut their price target on shares of HCA Healthcare from $304.00 to $273.00 and set an “outperform” rating on the stock in a report on Monday, April 25th. Finally, StockNews.com lowered shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, April 25th. Six research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average price target of $261.38.

In other HCA Healthcare news, major shareholder Thomas F. Frist, Jr. bought 89,100 shares of the firm’s stock in a transaction that occurred on Monday, May 2nd. The stock was acquired at an average price of $211.93 per share, with a total value of $18,882,963.00. Following the completion of the purchase, the insider now directly owns 478,955 shares of the company’s stock, valued at approximately $101,504,933.15. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Jennifer Berres sold 2,358 shares of the stock in a transaction that occurred on Friday, May 13th. The stock was sold at an average price of $218.87, for a total value of $516,095.46. Following the completion of the transaction, the senior vice president now owns 11,392 shares in the company, valued at approximately $2,493,367.04. The disclosure for this sale can be found here. Over the last quarter, insiders have bought 91,370 shares of company stock valued at $19,373,375 and have sold 14,380 shares valued at $3,723,203. Corporate insiders own 1.50% of the company’s stock.

Shares of NYSE:HCA traded up $2.58 during midday trading on Monday, reaching $207.36. The company’s stock had a trading volume of 19,378 shares, compared to its average volume of 1,789,797. The business’s fifty day simple moving average is $240.86 and its 200-day simple moving average is $244.51. The company has a debt-to-equity ratio of 87.46, a current ratio of 1.43 and a quick ratio of 1.24. The company has a market capitalization of $61.27 billion, a P/E ratio of 9.64, a P/E/G ratio of 1.30 and a beta of 1.61. HCA Healthcare, Inc. has a fifty-two week low of $198.69 and a fifty-two week high of $279.02.

HCA Healthcare (NYSE:HCAGet Rating) last released its quarterly earnings data on Friday, April 22nd. The company reported $4.12 earnings per share for the quarter, missing the consensus estimate of $4.25 by ($0.13). The business had revenue of $14.95 billion for the quarter, compared to the consensus estimate of $14.72 billion. HCA Healthcare had a net margin of 11.40% and a return on equity of 405.72%. The company’s revenue for the quarter was up 6.9% on a year-over-year basis. During the same quarter last year, the firm earned $4.14 EPS. On average, analysts forecast that HCA Healthcare, Inc. will post 17.15 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, June 30th. Shareholders of record on Thursday, June 16th will be issued a $0.56 dividend. This represents a $2.24 dividend on an annualized basis and a yield of 1.08%. The ex-dividend date is Wednesday, June 15th. HCA Healthcare’s dividend payout ratio is 10.54%.

HCA Healthcare announced that its board has initiated a share buyback program on Thursday, January 27th that permits the company to repurchase $8.00 billion in shares. This repurchase authorization permits the company to purchase up to 10.9% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company’s board of directors believes its stock is undervalued.

About HCA Healthcare (Get Rating)

HCA Healthcare, Inc, through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Read More

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAGet Rating).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.